Industry-oriented Investment Approach
GL Capital is China's leading value investor specialized in the healthcare sector,
focusing on buyout and significant minority opportunities
14
Years of track record, founded in 2010
$3.4
bOf AUM
$132
mOf GP investment (~4% of total AUM)
1.2
xGross DPI across all USD funds
<1
%Realized losses across private equity investments
in all USD funds
8|3.8
xBuyouts completed, including 4 exits /
gross MOIC across realized buyouts
Sub-sector Focus
Pharmaceuticals & Biotechnology
Specialty pharma
Branded OTCs
Innovative drugs
Medical Devices
Innovative medical equipment/devices
Laboratory consumables
Healthcare Services
Rehabilitation platforms
Specialty hospitals and clinics
IVD
Key raw materials
Reagents
CXO
CRO
CDMO
Others
Nutritional supplements
Animal health
Specialty APIs
Wound care
Case Studies
More Details on Portfolio Companies
